vimarsana.com
Home
Live Updates
IntelGenx Provides Regulatory Update for Xiromed-Partnered Development Candidate, Buprenorphine Buccal Film : vimarsana.com
IntelGenx Provides Regulatory Update for Xiromed-Partnered Development Candidate, Buprenorphine Buccal Film
SAINT LAURENT, Quebec, Sept. 19, 2023 -- IntelGenx Corp. today provided a regulatory update on Buprenorphine Buccal Film, for which an abbreviated new drug application has been filed with the...
Related Keywords
Quebec ,
Canada ,
Madrid ,
Spain ,
Saint Laurent ,
United States ,
Canadian ,
Andre Godin ,
Insud Pharma ,
Intelgenx Versafilm ,
Stephen Kilmer ,
Dwight Gorham ,
Exchange Commission ,
Drug Administration ,
Chemo Research ,
Securities Exchange ,
Intelgenx Corp ,
Company Or Intelgenx ,
Intelgenx Technologies Corp ,
Buprenorphine Buccal Film ,
Complete Response Letter ,
Amendment Acknowledgement ,
Generic Drug User Fee Act ,
Buccal Film ,
Florham Park ,
Looking Information ,
Securities Exchange Act ,
Securities Act ,
United States Securities ,
Intelgenx Technologies ,
Markets ,
vimarsana.com © 2020. All Rights Reserved.